RSS   Newsletter   Contact   Advertise with us
Post Online Media

Anavex Life Sciences adds Peter Donhauser to board

Anavex Life SciencesAnavex Life Sciences Corp., a biopharmaceutical company, announced the appointment of Peter Donhauser to its board of directors.
Article continues below

READ MORE Anavex Life Sciences elects Athanasios Skarpelos to the board

Dr. Donhauser has more than 20 years of expertise in clinical research followed by practicing osteopathic medicine with an integrated medical approach in private practice since 2000.

Dr. Donhauser worked at the University Hospital of Munich in the fields of geriatrics and neuromusculoskeletal diseases.

During this time, he was a clinical trial investigator in multiple Phase 3 studies, including studies sponsored by Merck Sharp & Dohme/Merck, Boehringer Mannheim/Roche, Servier and Sanofi.

Dr. Donhauser received his human medicine degree at the University of Munich and Doctor of Osteopathic Medicine (D.O.) from the DAAO and EROP at the Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy